Loading company…
Riskpilot
← Back to search
Sign in
Get full access
ALARMIN THERAPEUTICS AS
AS
Active
Org 932262770
Gaustadalléen 21, 0349 Oslo
Research and experimental development on natural sciences and engineering · NACE 7210
Est. 2023
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 124K
EBITDA margin
11.0%
+141% vs 2023
Equity ratio
101.0%
Financial strength
Net profit 2024
NOK 12K
+136% vs 2023
EBITDA — year on year
NOK millions
0M
-0M
-1M
-1M
-1M
0M
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
NOK 124K
—
EBITDA
NOK 14K
+141%
Net profit
NOK 12K
+136%
Total assets
NOK 3K
-92%
Equity
NOK 3K
+141%
Employees
0
—
Company information
Legal name
ALARMIN THERAPEUTICS AS
Org number
932262770
Legal form
Aksjeselskap
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
17. oktober 2023
Share capital
NOK 33 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder eller styrets leder hver for seg.
Company purpose
Forskning og utvikling av legemidler, eierskap av aksjer og patenter, og dertil tilhørende tjenester.
Contact
Address
Gaustadalléen 21, 0349 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Research and experimental development on natural sciences and engineering
Companies in Oslo
All Norway companies
Revenue
NOK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
Income statement
NOK thousands
Item
2023
2024
Revenue
0
124
Staff expenses
−0
−0
EBITDA
−33
14
Depreciation & amort.
−0
−0
EBIT
−33
14
Net financials
0
−2
Profit before tax
−33
12
Tax
−0
−0
Net profit
−33
12
Balance sheet
NOK thousands
Item
2023
2024
Total assets
41
3
Equity
−9
3
Long-term debt
0
0
Short-term debt
50
−0
Total debt
50
−0
Financial ratios
5-year trend
EBITDA margin
11.0%
This company
15.8%
Market median
-30% vs market
2023
2024
Equity ratio
101.0%
This company
38.2%
Market median
+164% vs market
2023
2024
Return on equity
344.9%
This company
18.4%
Market median
+1774% vs market
2023
2024
Net profit margin
9.7%
This company
8.1%
Market median
+20% vs market
2023
2024
Asset turnover
36.06×
This company
1.12×
Market median
+3120% vs market
2023
2024
Debt / equity
-0.01×
This company
0.62×
Market median
+102% vs market
2023
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-09-13 – 2023-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
EA
Esben Are Nilssen
Chief Executive Officer
Chief Executive Officer
2023
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
RI
Rizwan Iqbal Hussain
Chairman
2023
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of ALARMIN THERAPEUTICS AS also hold positions in
0
other companies.
Person
Role here
Other companies
Esben Are Nilssen
Chief Executive Officer
0 companies
Rizwan Iqbal Hussain
Chairman
0 companies